24
Participants
Start Date
April 1, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Henagliflozin
Henagliflozin will be initiated and maintained at 5mg/day every morning. If necessary, the dose can be increased to 10mg once daily. All patients will also continue on their existing dose and regimen of metformin throughout the study.
Gliclazide
Gliclazide will be initiated and maintained at 30mg/day every morning. If necessary, the dose can be increased to 120mg once daily. All patients will also continue on their existing dose and regimen of metformin throughout the study.
Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER